Ligands of Immunopharmacology

ODN 24987 is a Guanine-modified inhibitory oligonucleotides (ODN), targeting TLR9 . ODN 24987 can inhibit IL-6 and IFN-α release. ODN 24987 can be used for research immune disorders. ODN 24987 sequence: 5’-C-C-T-G-G-C-c7G-G-G-G-3’In VitroODN 24987

ODN 24991, a guanine-modified inhibitory oligonucleotide (INH-ODN), is a TLR3 , TLR7 and TLR9 (Toll-like receptor) inhibitor, and its parent is INH-ODN 2088. ODN 24991 disrupts TLR3-, TLR7- and TLR9-mediated immune cell immune responses. ODN 24991

ODN 24991, a guanine-modified inhibitory oligonucleotide (INH-ODN), is a TLR3 , TLR7 and TLR9 (Toll-like receptor) inhibitor, and its parent is INH-ODN 2088. ODN 24991 disrupts TLR3-, TLR7- and TLR9-mediated immune cell immune responses. ODN 24991

ODN 24991, a guanine-modified inhibitory oligonucleotide (INH-ODN), is a TLR3 , TLR7 and TLR9 (Toll-like receptor) inhibitor, and its parent is INH-ODN 2088. ODN 24991 disrupts TLR3-, TLR7- and TLR9-mediated immune cell immune responses. ODN 24991

ODN 6016 is a CpG-A oligonucleotides . ODN 6016 can induce IFN-α production, can be used for researching immune disorders including immunodeficiency caused by HIV-1 . ODN 6016 sequence: T-sp-C-G-A-C-G-T-C-G-T-G-G-sp-G-sp-G-sp-GForm:SolidIC50&amp

ODN 6016 is a CpG-A oligonucleotides . ODN 6016 can induce IFN-α production, can be used for researching immune disorders including immunodeficiency caused by HIV-1 . ODN 6016 sequence: T-sp-C-G-A-C-G-T-C-G-T-G-G-sp-G-sp-G-sp-GForm:SolidIC50&amp

ODN 6016 is a CpG-A oligonucleotides . ODN 6016 can induce IFN-α production, can be used for researching immune disorders including immunodeficiency caused by HIV-1 . ODN 6016 sequence: T-sp-C-G-A-C-G-T-C-G-T-G-G-sp-G-sp-G-sp-GForm:SolidIC50&amp

ODN D-SL01, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN D-SL01 has strong immunostimulatory activity in a variety of vertebrate species and has anticancer activity. ODN D-SL01 sequence: 5'-

ODN D-SL01, a class B CpG ODN (oligodeoxynucleotide), is a TLR9 agonist. ODN D-SL01 has strong immunostimulatory activity in a variety of vertebrate species and has anticancer activity. ODN D-SL01 sequence: 5'-

ODN D-SL03 is a C class CpG oligonucleotides , can induce stimulate PBMCs to produce high level of IFN-α . ODN D-SL03 can activate human B cells, NK cells and mononuclear cells and up-regulate expression of CD80, CD86 and HLA-DR on the surface of

ODN D-SL03 is a C class CpG oligonucleotides , can induce stimulate PBMCs to produce high level of IFN-α . ODN D-SL03 can activate human B cells, NK cells and mononuclear cells and up-regulate expression of CD80, CD86 and HLA-DR on the surface of

ODN D-SL03 is a C class CpG oligonucleotides , can induce stimulate PBMCs to produce high level of IFN-α . ODN D-SL03 can activate human B cells, NK cells and mononuclear cells and up-regulate expression of CD80, CD86 and HLA-DR on the surface of